SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
|Filed by the Registrant.||x|
|Filed by a Party other than the Registrant||¨|
Check the appropriate box:
|¨||Preliminary Proxy Statement|
|¨||Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))|
|¨||Definitive Proxy Statement|
|x||Definitive Additional Materials|
|¨||Soliciting Material under §240.14a-12|
(Name of Registrant as Specified In Its Charter)
Payment of Filing Fee (Check the appropriate box):
|x||No fee required|
|¨||Fee paid previously with preliminary materials.|
|¨||Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11|
The following is a letter sent to certain shareholders of Avenue Therapeutics, Inc. in a mailing commenced on January 17, 2023
Dear Avenue Therapeutics’ Shareholder:
YOUR PARTICIPATION IS IMPORTANT – PLEASE VOTE TODAY!
According to our latest records, your proxy vote relating to the Avenue Therapeutics’ Annual Meeting of Stockholders has not yet been received.
have until January 29, 2023 at 11:59 p.m. EST to vote your shares.|
PLEASE VOTE TODAY following the instructions on your proxy card.
|Item 1||ELECTION OF DIRECTORS||Vote FOR|
|Item 2||RATIFY BDO USA, LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTANT||Vote FOR|
|Item 3||APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK||Vote FOR|
|Item 4||APPROVE AN AMENDMENT TO OUR 2015 EQUITY INCENTIVE PLAN||Vote FOR|
If you have any questions please contact our proxy solicitor, Alliance Advisors, toll free at: 1-855-506-1762
If you have recently mailed your proxy card or cast your vote by phone or internet, please accept our thanks and disregard this request.
Alexandra MacLean, M.D.
Chief Executive Officer